10/29/2026 13:00
LeBron James Deepens Commitment to WHOOP, Expanding 11-Year Relationship

One of the first 100 WHOOP members, James strengthens his commitment to the human performance company as the two partner to advance the future of performance, health, and longevity. WHOOP , the human performance brand, today announced that basketball legend LeBron James has joined as a global ambassador, formalizing a relationship that began more than a decade ago. One of the company's earliest members and now an investor, James will partner with WHOOP to champion the importance of sustained ath...

10/29/2026 13:00
Xsolla Acquires GamePix to Build a Complete Platform for Web and AI-Created Video Games

GamePix’s Web Publishing and Distribution Join Xsolla’s Global Commerce Infrastructure, Giving Developers One Path From Video Game to Players Worldwide Xsolla, a global commerce company, today announced it acquired GamePix, the web games platform that publishes and distributes browser games worldwide. GamePix brings a catalog of 10,000+ web titles, a community of 4,000+ developers, and a publishing solution that brings any game to your web browser, from PC and mobile titles ported with its own t...

10/27/2026 10:30
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that it will release financial results for the third quarter ended September 30, 2026, and provide an update on recent developments, on November 3, 2026. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 3, 2026. A live webcast of the call will be available at the following link: https://lifescievents....

Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo®) in Patients With Mycosis Fungoides and Sézary Syndrome

Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one of the largest real-world evaluations of mogamulizumab in Germany and...
Anglais

Omdia: Global XR headwear shipments fall 39% in 1H26 as XR glasses growth fails to offset headset decline

Global shipments of XR headwear declined 38.7% year-on-year to 1.9 million units in the first half of 2026, according to the latest data from Omdia. While XR glasses are gaining traction, their growth from a small base was insufficient to counter a steep drop in XR headset shipments. By 2025, the market had recorded...
Anglais

PAX Debuts The Oxblood Edit, a Limited Edition Collection Inspired by Fall’s Richest Color

TodayPAX, a pioneering global cannabis brand, introduces The Oxblood Edit, an ultra-limited release bringing one of fall’s defining colors to three of the brand’s signature devices: PAX FOUR, PAX MINI and ERA GO. Deep, distinctive and designed to be coveted, Oxblood transforms the PAX lineup through a rich burgundy finish inspired by the worlds of fashion, interiors and industrial design. The...
Anglais
Subscribe to